DE2534964A1 - Fluorierte amide der nikotinsaeure und ein verfahren zu seiner herstellung - Google Patents

Fluorierte amide der nikotinsaeure und ein verfahren zu seiner herstellung

Info

Publication number
DE2534964A1
DE2534964A1 DE19752534964 DE2534964A DE2534964A1 DE 2534964 A1 DE2534964 A1 DE 2534964A1 DE 19752534964 DE19752534964 DE 19752534964 DE 2534964 A DE2534964 A DE 2534964A DE 2534964 A1 DE2534964 A1 DE 2534964A1
Authority
DE
Germany
Prior art keywords
trifluoromethyl
nicotinic acid
acid
nitro
anilide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752534964
Other languages
German (de)
English (en)
Inventor
Enrico Diamanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE2534964A1 publication Critical patent/DE2534964A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752534964 1974-09-05 1975-08-05 Fluorierte amide der nikotinsaeure und ein verfahren zu seiner herstellung Ceased DE2534964A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT52879/74A IT1043918B (it) 1974-09-05 1974-09-05 Ammidi fluorurate dell acido nicotinico e procedimento per loro preparazione

Publications (1)

Publication Number Publication Date
DE2534964A1 true DE2534964A1 (de) 1976-03-25

Family

ID=11278222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752534964 Ceased DE2534964A1 (de) 1974-09-05 1975-08-05 Fluorierte amide der nikotinsaeure und ein verfahren zu seiner herstellung

Country Status (7)

Country Link
JP (1) JPS5811865B2 (cg-RX-API-DMAC10.html)
BE (1) BE833115A (cg-RX-API-DMAC10.html)
DE (1) DE2534964A1 (cg-RX-API-DMAC10.html)
FR (1) FR2283680A1 (cg-RX-API-DMAC10.html)
GB (1) GB1483138A (cg-RX-API-DMAC10.html)
IT (1) IT1043918B (cg-RX-API-DMAC10.html)
SE (1) SE416466B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2365265A (en) * 1941-08-30 1944-12-19 Du Pont Insoluble azo dyes
US3462532A (en) * 1967-08-28 1969-08-19 Dow Chemical Co Controlling gastropods with nicotinanilide or alkylaryl nicotinamide gastropodicides

Also Published As

Publication number Publication date
JPS51125086A (en) 1976-11-01
JPS5811865B2 (ja) 1983-03-04
GB1483138A (en) 1977-08-17
FR2283680B1 (cg-RX-API-DMAC10.html) 1979-08-10
FR2283680A1 (fr) 1976-04-02
BE833115A (fr) 1975-12-31
IT1043918B (it) 1980-02-29
SE7509692L (sv) 1976-03-08
SE416466B (sv) 1981-01-05

Similar Documents

Publication Publication Date Title
DE1815922A1 (de) 5-Phenyltetrazol-Derivate
DE2147023B2 (de) Verfahren zur Herstellung von 1H- Tetrazol-Verbindungen
DE2534964A1 (de) Fluorierte amide der nikotinsaeure und ein verfahren zu seiner herstellung
DE2022656A1 (de) Aminoaethansulfonylderivate und Verfahren zu ihrer Herstellung
DE1111208B (de) Verfahren zur Herstellung von hustenreizstillend wirkenden, basisch substituierten Diphenylcarbinolestern
DE2602846C2 (de) Verfahren zur Herstellung von 2-(2-Thienyl)äthylaminen
AT363074B (de) Verfahren zur herstellung von neuen 1-amino-niedrig-alkyl-3,4-diphenyl-1h-pyrazolen und ihren salzen
DE69913133T2 (de) Verfahren zur herstellung von aceclofenac
DE2704621C2 (cg-RX-API-DMAC10.html)
DE2525962A1 (de) Neue heterocyclische verbindungen, ihre herstellung und verwendung
DE1670143C3 (cg-RX-API-DMAC10.html)
CH473821A (de) Verfahren zur Herstellung von Iminodibenzyl-Derivaten
CH497440A (de) Verfahren zur Herstellung von Piperazylalkylderivaten von Tetrazolen
CH359703A (de) Verfahren zur Herstellung von neuen Piperidinen
DE2728870C2 (de) Verfahren zur Herstellung von D-Penicillamin und dessen Salzen
DE1643458C3 (de) N-(2-Alkoxybenzoyl)-p-aminobenzoesäure-aminoalkylester sowie deren quartäre Methylammoniumderivate und Verfahren zu ihrer Herstellung
AT236389B (de) Verfahren zur Herstellung von neuen N-substituierten heterocyclischen Verbindungen
AT303739B (de) Verfahren zur Herstellung von 1-Hydroxyyalkylbenzodiazepinderivaten sowie von Salzen dieser Verbindungen
AT211296B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäuren
AT349474B (de) Verfahren zur herstellung von neuen, basisch substituierten 3,4-dihydro-2h-isochinolin-1- thionen und ihren salzen
AT235282B (de) Verfahren zur Herstellung von neuen Β-Carbolinderivaten
AT238160B (de) Verfahren zur Herstellung von neuen Dihalogen-amino-benzylaminen und deren Säureadditionssalzen mit anorganischen oder organischen Säuren
DE1815450C (de) Spiro(4,5)decanverbindungen
AT205977B (de) Verfahren zur Herstellung von neuen, heterocyclischen Hydrazinderivaten
DE1443604C3 (de) 1 -Aminomethyl-1,2-dihydro-benzocyclobuten und einige seiner Derivate, Salze dieser Verbindungen, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2560497

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2560497

8131 Rejection